Literature DB >> 33631117

Dissecting the impact of regional identity and the oncogenic role of human-specific NOTCH2NL in an hESC model of H3.3G34R-mutant glioma.

Kosuke Funato1, Ryan C Smith2, Yuhki Saito3, Viviane Tabar4.   

Abstract

H3.3G34R-mutant gliomas are lethal tumors of the cerebral hemispheres with unknown mechanisms of regional specificity and tumorigenicity. We developed a human embryonic stem cell (hESC)-based model of H3.3G34R-mutant glioma that recapitulates the key features of the tumors with cell-type specificity to forebrain interneuronal progenitors but not hindbrain precursors. We show that H3.3G34R, ATRX, and TP53 mutations cooperatively impact alternative RNA splicing events, particularly suppression of intron retention. This leads to increased expression of components of the Notch pathway, notably NOTCH2NL, a human-specific gene family. We also uncover a parallel mechanism of enhanced NOTCH2NL expression via genomic amplification of its locus in some H3.3G34R-mutant tumors. These findings demonstrate a novel mechanism whereby evolutionary pathways that lead to larger brain size in humans are co-opted to drive tumor growth.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ATRX; H3.3G34R; NOTCH2NL; Pluripotent stem cells; TP53; cancer models; high-grade glioma; hindbrain progenitors; histone-mutant glioma; interneuron progenitors; ventral forebrain

Mesh:

Substances:

Year:  2021        PMID: 33631117      PMCID: PMC8106629          DOI: 10.1016/j.stem.2021.02.003

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  48 in total

1.  ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays.

Authors:  Yifang Hu; Gordon K Smyth
Journal:  J Immunol Methods       Date:  2009-06-28       Impact factor: 2.303

2.  BS69/ZMYND11 reads and connects histone H3.3 lysine 36 trimethylation-decorated chromatin to regulated pre-mRNA processing.

Authors:  Rui Guo; Lijuan Zheng; Juw Won Park; Ruitu Lv; Hao Chen; Fangfang Jiao; Wenqi Xu; Shirong Mu; Hong Wen; Jinsong Qiu; Zhentian Wang; Pengyuan Yang; Feizhen Wu; Jingyi Hui; Xiangdong Fu; Xiaobing Shi; Yujiang Geno Shi; Yi Xing; Fei Lan; Yang Shi
Journal:  Mol Cell       Date:  2014-09-25       Impact factor: 17.970

3.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

4.  Spatiotemporal gene expression trajectories reveal developmental hierarchies of the human cortex.

Authors:  Tomasz J Nowakowski; Aparna Bhaduri; Alex A Pollen; Beatriz Alvarado; Mohammed A Mostajo-Radji; Elizabeth Di Lullo; Maximilian Haeussler; Carmen Sandoval-Espinosa; Siyuan John Liu; Dmitry Velmeshev; Johain Ryad Ounadjela; Joe Shuga; Xiaohui Wang; Daniel A Lim; Jay A West; Anne A Leyrat; W James Kent; Arnold R Kriegstein
Journal:  Science       Date:  2017-12-08       Impact factor: 47.728

5.  H3.3 G34R mutations in pediatric primitive neuroectodermal tumors of central nervous system (CNS-PNET) and pediatric glioblastomas: possible diagnostic and therapeutic implications?

Authors:  Marco Gessi; Gerrit H Gielen; Jennifer Hammes; Evelyn Dörner; Anja Zur Mühlen; Andreas Waha; Torsten Pietsch
Journal:  J Neurooncol       Date:  2013-01-26       Impact factor: 4.130

6.  ZMYND11 links histone H3.3K36me3 to transcription elongation and tumour suppression.

Authors:  Hong Wen; Yuanyuan Li; Yuanxin Xi; Shiming Jiang; Sabrina Stratton; Danni Peng; Kaori Tanaka; Yongfeng Ren; Zheng Xia; Jun Wu; Bing Li; Michelle C Barton; Wei Li; Haitao Li; Xiaobing Shi
Journal:  Nature       Date:  2014-03-02       Impact factor: 49.962

7.  A versatile viral system for expression and depletion of proteins in mammalian cells.

Authors:  Eric Campeau; Victoria E Ruhl; Francis Rodier; Corey L Smith; Brittany L Rahmberg; Jill O Fuss; Judith Campisi; Paul Yaswen; Priscilla K Cooper; Paul D Kaufman
Journal:  PLoS One       Date:  2009-08-06       Impact factor: 3.240

8.  Progenetix: 12 years of oncogenomic data curation.

Authors:  Haoyang Cai; Nitin Kumar; Ni Ai; Saumya Gupta; Prisni Rath; Michael Baudis
Journal:  Nucleic Acids Res       Date:  2013-11-12       Impact factor: 16.971

9.  Inhibition of a K9/K36 demethylase by an H3.3 point mutation found in paediatric glioblastoma.

Authors:  Hsiao P J Voon; Maheshi Udugama; Wendi Lin; Linda Hii; Ruby H P Law; David L Steer; Partha P Das; Jeffrey R Mann; Lee H Wong
Journal:  Nat Commun       Date:  2018-08-07       Impact factor: 14.919

10.  Evolution of Human Brain Size-Associated NOTCH2NL Genes Proceeds toward Reduced Protein Levels.

Authors:  Gerrald A Lodewijk; Diana P Fernandes; Iraklis Vretzakis; Jeanne E Savage; Frank M J Jacobs
Journal:  Mol Biol Evol       Date:  2020-09-01       Impact factor: 16.240

View more
  8 in total

Review 1.  Oncohistones: Exposing the nuances and vulnerabilities of epigenetic regulation.

Authors:  Michelle M Mitchener; Tom W Muir
Journal:  Mol Cell       Date:  2022-08-18       Impact factor: 19.328

Review 2.  Brain cancer stem cells: resilience through adaptive plasticity and hierarchical heterogeneity.

Authors:  Ryan C Gimple; Kailin Yang; Matthew E Halbert; Sameer Agnihotri; Jeremy N Rich
Journal:  Nat Rev Cancer       Date:  2022-06-16       Impact factor: 69.800

Review 3.  The Intricate Epigenetic and Transcriptional Alterations in Pediatric High-Grade Gliomas: Targeting the Crosstalk as the Oncogenic Achilles' Heel.

Authors:  Paul Huchedé; Pierre Leblond; Marie Castets
Journal:  Biomedicines       Date:  2022-06-03

4.  Epigenetically defined therapeutic targeting in H3.3G34R/V high-grade gliomas.

Authors:  Stefan R Sweha; Chan Chung; Siva Kumar Natarajan; Pooja Panwalkar; Matthew Pun; Amer Ghali; Jill Bayliss; Drew Pratt; Anand Shankar; Visweswaran Ravikumar; Arvind Rao; Marcin Cieslik; Kari Wilder-Romans; Andrew J Scott; Daniel R Wahl; Selin Jessa; Claudia L Kleinman; Nada Jabado; Alan Mackay; Chris Jones; Daniel Martinez; Mariarita Santi; Alexander R Judkins; Viveka Nand Yadav; Tingting Qin; Timothy N Phoenix; Carl J Koschmann; Suzanne J Baker; Arul M Chinnaiyan; Sriram Venneti
Journal:  Sci Transl Med       Date:  2021-10-13       Impact factor: 19.319

Review 5.  Radiosensitization in Pediatric High-Grade Glioma: Targets, Resistance and Developments.

Authors:  Dennis S Metselaar; Aimée du Chatinier; Iris Stuiver; Gertjan J L Kaspers; Esther Hulleman
Journal:  Front Oncol       Date:  2021-04-01       Impact factor: 6.244

6.  NOTCH2NLA silencing inhibits ovarian carcinoma progression and oncogenic activity in vivo and in vitro.

Authors:  Wendi Guo; Zhen Sun; Nannan Zhao; Yiwen Zhou; Jie Ren; Lingling Huang; Yi Ping
Journal:  Ann Transl Med       Date:  2021-11

7.  Oncohistone interactome profiling uncovers contrasting oncogenic mechanisms and identifies potential therapeutic targets in high grade glioma.

Authors:  Robert Siddaway; Laura Canty; Sanja Pajovic; Scott Milos; Etienne Coyaud; Stefanie-Grace Sbergio; Arun Kumaran Vadivel Anguraj; Evan Lubanszky; Hwa Young Yun; Alessia Portante; Sheyenne Carette; Cunjie Zhang; Michael F Moran; Brian Raught; Eric I Campos; Cynthia Hawkins
Journal:  Acta Neuropathol       Date:  2022-09-07       Impact factor: 15.887

Review 8.  Polycomb repressive complex 2 in the driver's seat of childhood and young adult brain tumours.

Authors:  Brian Krug; Ashot S Harutyunyan; Shriya Deshmukh; Nada Jabado
Journal:  Trends Cell Biol       Date:  2021-06-03       Impact factor: 21.167

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.